Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,242,780
+$14,702,761 QoQ
Shares Held
104,287
+96.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#526
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2025CallValue
$5,826,495
CallShares
25,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $100,420,553 across 10 Drug Manufacturers - General names. ABBV ranks #2 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
240,327 | $48,495,411 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
104,287 | $26,242,780 | |
| 3 | GSK |
GSK plc
|
199,265 | $10,445,471 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
57,030 | $7,205,170 | |
| 5 | NVS |
Novartis AG
|
16,468 | $2,580,864 | |
| 6 | MRK |
Merck & Co., Inc.
|
15,528 | $1,995,348 | |
| 7 | JNJ |
Johnson & Johnson
|
6,461 | $1,640,900 | |
| 8 | SNY |
Sanofi
|
15,897 | $678,166 |
All Filings in ABBV
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,242,780 | 104,287 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,540,019 | 53,060 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,826,495 | 25,500 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $4,599,046 | 20,128 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,520,650 | 32,481 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,958,291 | 10,550 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,834,216 | 18,300 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $2,756,654 | 13,157 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $3,834,216 | 18,300 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $2,359,322 | 13,277 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,714,955 | 13,748 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,489,651 | 8,685 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $571,794 | 3,140 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $728,903 | 4,890 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $222,978 | 1,655 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,540,525 | 59,864 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,518,829 | 58,900 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,684,593 | 72,160 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $270,174 | 1,764 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $810,550 | 5,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,718,761 | 27,465 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,157,111 | 57,079 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $12,300,851 | 109,205 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $6,311,390 | 58,320 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,514,015 | 42,128 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,524,476 | 63,072 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $2,474,626 | 25,205 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,711,303 | 22,461 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||